CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure

CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure

Abstract Background Cervical cancer is the tenth diagnosed cancer in the world. Early-stage and locally recurrent disease may be cured with radical surgery or chemo-radiotherapy. However, if disease persists or recurs, options are limited and the prognosis is poor. In addition to chemotherapy, bevac...

Full description

Bibliographic Details
Main Authors: Elodie Coquan, Pierre-Emmanuel Brachet, Idlir Licaj, Alexandra Leconte, Marie Castera, Justine Lequesne, Emeline Meriaux, Isabelle Bonnet, Anais Lelaidier, Bénédicte Clarisse, Florence Joly
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Cancer
Subjects:
Cabozantinib
Metastatic cervical carcinoma
Quality of life
Anti angiogenic treatment
Online Access:https://doi.org/10.1186/s12885-021-08758-9

Internet

https://doi.org/10.1186/s12885-021-08758-9

Similar Items